We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Benign Hematology

Journal Scan / Research · November 25, 2021

Cost of Eltrombopag vs IVIG for Perioperative Management of ITP

Blood advances


Additional Info

Blood advances
Cost-effectiveness of eltrombopag versus intravenous immunoglobulin for the perioperative management of immune thrombocytopenia
Blood Adv 2021 Nov 15;[EPub Ahead of Print], MN Kaur, DM Arnold, NM Heddle, RJ Cook, CC Hsia, M Blostein, E Jamula, M Sholzberg, Y Lin, J Kassis, L Larratt, AT Tinmouth, J Carruthers, N Li, Y Liu, F Xie

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading